Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients
Study Details
Study Description
Brief Summary
A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 279 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period. Primary outcome is the level of physical activity measured with an accelerometer. Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.
Nurses will be trained in delivering the intervention by a one-day training and coaching sessions supervised. A process evaluation will be conducted.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Self-management interventions are considered effective in chronic disease patients, but trials have shown inconsistent results and it is unknown which patients benefit most. Adequate self-management requires behaviour change in patients and in healthcare providers to equip them in supporting patients in changing their behaviour. To unravel effectiveness of self-management, a nurse-led intervention was developed targeting at one self-management behaviour, namely physical activity, in primary care patients at risk for cardiovascular disease: the Activate intervention. This study aims to evaluate the effectiveness of the Activate intervention, to identify which patient-related characteristics modify change in physical activity levels in patients at risk for CVD in primary care, and to conduct a process evaluation.
A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 300 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period in which 17 behaviour change techniques (BCTs) are integrated. Primary outcome is the level of physical activity measured with an accelerometer . Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.
Subsequently, the BCW was applied to analyse what behavior change is needed in nurses to deliver the Activate intervention adequately. This resulted in a one-day training and coaching sessions supervised by a health psychologist and included 21 BCT.
A process evaluation will be conducted to evaluate the training of nurses, fidelity, dose and reach of the Activate intervention, identify barriers and facilitators for implementation and to assess participants' satisfaction.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention: Activate intervention Participants in the intervention arm will visit their primary care nurse four times in a three-month period for structured and comprehensive support in achieving an improved level of physical activity. |
Behavioral: Activate
The Activate intervention consists of four nurse-led consultations in a thee-month period. In the consultations patients receive structured and comprehensive support in achieving an improved level of physical activity. The Behavior Change Wheel was used to develop the Activate intervention, and led to a selection of 17 behavior change techniques, which are integrated in the Activate intervention
|
No Intervention: Control Patients in the control arm will receive care as usual. |
Outcome Measures
Primary Outcome Measures
- level of physical activity measured with the Personal Activity Monitor (PAM AM300) [baseline - 6 months of follow up]
The amount of minutes of physical activity in the moderate (3-6 METabolic equivalent (METS)) and vigorous categories (≥6 METS) at 6 months of follow up will be considered as primary outcome measure. Patients will be asked to wear the accelerometer during 7 consecutive days for 12 hours a day at baseline (T0), 3 months of follow up (T1) and at 6 months of follow up (T2).
Secondary Outcome Measures
- Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS) [baseline -3 months and 6 months of follow up]
Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)
- Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS) [baseline - 3 months and 6 months of follow up]
Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS), baseline, T0, T1, T2
- Patient activation using the Patient Activation Measure (PAM-13) [baseline -3 months and 6 months of follow up]
Patient activation using the Patient Activation Measure (PAM-13)
- Health status using the EQ-5D [baseline - 6 months of follow up]
Health status using the EQ-5D
Other Outcome Measures
- Potential effect modifier: age [baseline]
does age modify change in physical activity level
- Potential effect modifier: depression using the Hospital Anxiety and Depression Scale (HADS) [baseline]
does depression modify change in physical activity level
- Potential effect modifier: Body Mass Index (BMI) [baseline]
does BMI modify change in physical activity level
- Potential effect modifier: level of education [baseline]
does education level modify change in physical activity
- Potential effect modifier: social support using Multidimensional Scale of Perceived Social Support (MSPSS) [baseline,]
does social support modify change in level of physical activity
- Potential effect modifier: patient-provider relationship using the Communication Assessment Tool (CAT) [baseline, 3 months and 6 months of follow up]
does the patient-provider relationship modify change in level of physical activity
- Potential effect modifier: baseline amount of minutes of moderate to vigorous level of physical activity using the PAM AM300 [baseline]
does baseline amount of minutes of moderate to vigorous level of physical activity modify change in level of physical activity
Eligibility Criteria
Criteria
Inclusion Criteria:
Aged 40-75
AND at least one of the following criteria:
-
have a high blood pressure (≥ 140 mmHg) or are already treated for high blood pressure
-
have a high total cholesterol (≥ 6.5 mmol/l) or already treated for high cholesterol
-
have diabetes mellitus type 2 (DM2)
-
have a positive family history of CVD AND Do not meet the Dutch Norm for Healthy Exercise according to the Short QUestionnaire to Asses Health (SQUASH).
Exclusion Criteria:
-
unable to give informed consent (eg. due to cognitive impairment),
-
unable to speak, write and read Dutch,
-
have contra-indications to increase their physical activity level (eg. unstable angina pectoris, unstable heart failure, acute illness)
-
have a terminal illness or have severe psychiatric illness or chronic disorder(s) that seriously influence the ability to improve their psychical activity level.
-
patients should not have participated in a program to increase their level of physical activity in the past 2 years.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | GP Lienderweg | Asten | Brabant | Netherlands | 5721CM |
2 | GP Timmerman | Drunen | Brabant | Netherlands | 5151 HA |
3 | GP Emmers | s Hertogenbosch | Brabant | Netherlands | 5235KG |
4 | GP Klaar and Vincent | Ede | Gelderland | Netherlands | 6713 NS |
5 | GP Parklaan | Hoevelaken | Gelderland | Netherlands | 3871EE |
6 | GP Buren | Buren | Gerlderland | Netherlands | 4116CW |
7 | GP Seinhorst | Hilversum | Noord Holland | Netherlands | 1223DT |
8 | GP Tjin a Ton and Parlevliet | Amstelveen | Noord-Holland | Netherlands | 1186PJ |
9 | GP De Kennemerpoort | Bennebroek | Noord-Holland | Netherlands | 2121BB |
10 | GP Odijk-Visser | Heerhugowaard | Noord-Holland | Netherlands | 1701 ER |
11 | GP Munster | Heerhugowaard | Noord-Holland | Netherlands | 1701ER |
12 | GP Eedenburgh | Hilversum | Noord-Holland | Netherlands | 1215EK |
13 | GP Koedijk | Koedijk | Noord-Holland | Netherlands | 1831EK |
14 | GP De Hollenhorst | Nieuw Vennep | Noord-Holland | Netherlands | 2152CA |
15 | GP Spelt | Wassenaar | Noord-Holland | Netherlands | 2241KE |
16 | GP Jonker | Colmschate | Overijssel | Netherlands | 7429BG |
17 | GP Amarant | Kampen | Overijssel | Netherlands | 8265 DN |
18 | GP Rosing and Bruins Slot | Markelo | Overijssel | Netherlands | 7475AG |
19 | GP Blanker, Thiele, Brand | Zwolle | Overijssel | Netherlands | 8042AD |
20 | GP Provostlaan | Bilthoven | Utrecht | Netherlands | 3723RC |
21 | GP van Steenis | Bunnik | Utrecht | Netherlands | 3981EV |
22 | GP De Bilt | De BIlt | Utrecht | Netherlands | 3732BG |
23 | GP Tolgaarde | Leusden | Utrecht | Netherlands | 3831JR |
24 | GP Odijk | Odijk | Utrecht | Netherlands | 3984MA |
25 | GP De Schans | Woudenberg | Utrecht | Netherlands | 3931 KJ |
26 | GP Sparreboom | Alphen aan den Rijn | Zuid-Holland | Netherlands | 2408 LA |
27 | GP Wiechen | Boskoop | Zuid-Holland | Netherlands | 2771 EN |
28 | GP De Wiel | Schoonrewoerd | Zuid-Holland | Netherlands | 4145NV |
29 | GP Mozaiek | The Hague | Zuid-Holland | Netherlands | 2525CE |
30 | GP Loudon | The Hague | Zuid-Holland | Netherlands | 2593WB |
31 | GP Lombok | Utrecht | Netherlands | 3531 HX |
Sponsors and Collaborators
- UMC Utrecht
- ZonMw: The Netherlands Organisation for Health Research and Development
Investigators
- Study Chair: Marieke J. Schuurmans, PhD, UMC Utrecht
- Principal Investigator: Heleen Westland, MSc, UMC Utrecht
- Principal Investigator: Irene D Bos-Touwen, MSc, UMC Utrecht
- Study Chair: Jaap CA Trappenburg, PhD, UMC Utrecht
- Study Chair: Carin D Schröder, PhD, UMC Utrecht
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NL54286.041.15